C ornea is an avascular tissue and must remain transparent to refract light properly. Neovascularization in cornea resulting from various inflammatory disorders such as trauma, microbial infection, alkali burn, and limbal stem cell deficiency can impair vision. Cytokines and growth factors orchestrate cell behaviors in the development of corneal neovascularization.
1,2 Vascular endothelial growth factor (VEGF) and transforming growth factor ␤ (TGF␤) are two major cytokines involved in injury-induced neovascularization. [3] [4] [5] [6] These cytokines are upregulated in corneal stroma (inflammatory cells and resident corneal cells) during wound healing and inflammatory disorders. 7 Tumor necrosis factor ␣ (TNF␣) is a pleiotropic proinflammatory cytokine. 8 However, the role of TNF␣ in the development of neovascularization in injured tissues remains largely elusive because results of experiments that examined the roles of TNF␣ on the pathogenesis of different fibrotic and inflammatory disorders were controversial. For example, it has been shown that the suppression of TNF␣ by the administration of neutralizing antibody yields a favorable clinical outcome by reducing inflammation. 9, 10 This observation is substantiated by the finding that the ablation of TNF␣-receptor (Tnfr -/-) in mice is beneficial in pulmonary fibrosis caused by asbestos. 11 Studies using TNF␣-null (Tnf␣ -/-) and Tnfr -/-mice demonstrated more severe bleomycin-induced pulmonary fibrosis than did wildtype (WT) mice. It has also been reported that the overexpression of TNF␣ suppresses such bleomycin-induced pulmonary fibrosis. [12] [13] [14] These findings imply that TNF␣ signaling may have a role in modulating inflammatory responses and fibrosis. Therefore, adding TNF␣ may have beneficial effects on reducing certain types of pathogenic fibrosis while producing adverse effects on others. The pleiotropic roles of TNF␣ on various pathogenic disorders are further substantiated by the results of studies with collagen-induced arthritis (CIA) in Tnf␣ -/-mice that exhibited some reduction in the clinical parameters of CIA and, on histologic examination, significantly more normal joints. However, severe disease was evident in 54% of arthritic Tnf␣ -/-joints. Interestingly, collagen-immunized Tnf␣ -/-mice developed lymphadenopathy and splenomegaly. 15 We previously reported that endogenous TNF␣ could subdue TGF␤1-mediated tissue damage by alkali burn to the ocular surface, as exemplified by the greater severity of tissue damage in Tnf␣ -/-than in WT mice. The tissue damage caused by alkali burn in Tnf␣ -/-mice was accompanied by excess inflammation, myofibroblast generation, and marked neovascularization. 16 Results of our previous studies of Smad7 gene transfer 17 to alkali-burned cornea and bone marrow transplantation from WT mice to Tnf␣ -/-mice and in vitro coculture experiments revealed that macrophage-derived TNF␣ could counteract the effect of TGF␤ on fibrotic or inflammatory reaction of the alkali-burned cornea. 16, 17 However, in our previous study, an alkali burn with sodium hydroxide eyedrop damaged large areas of ocular tissue, including cornea, limbus, and bulbar conjunctiva. Thus, healed corneal surfaces were covered by conjunctival epithelium in WT and Tnf␣ -/-mice. 7, 16, 17 Therefore, it remains unknown whether such marked corneal neovascularization observed in Tnf␣ -/-mice is associated with an invasion of conjunctival epithelium into the affected cornea or by a lack of TNF␣ alone. In the present study, to uncover the role of endogenous TNF␣ in the development of corneal neovascularization, we compared in vivo neovascularization by cauterization in WT and Tnfa -/-mice and also examined the effects of TNF␣ on neovascularization using an in vitro model of cultured vascular endothelial cells. Our data indicated that TNF␣ might directly block neovascularization while it suppressed TGF␤1 and VEGF expression by fibroblasts in situ.
MATERIALS AND METHODS
Experiments were approved by the DNA Recombination Experiment Committee and the Animal Care and Use Committee of Wakayama Medical University and were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Effects of TNF␣ and TGF␤1 on VEGF Expression in Ocular Fibroblasts
Real-time reverse transcription-polymerase chain reaction (RT-PCR) with TaqMan probes was used to examine the effect of TNF␣ on VEGF expression by corneal fibroblasts using protocols previously described. 16 Corneal stromal cells derived from explant outgrowth of 2-day-old mice were obtained. Confluent cells were treated with human recombinant TGF␤1 (2 ng/mL; R&D Systems, Minneapolis, MN) or combination TGF␤1 (2 ng/mL) and TNF␣ (5 or 10 ng/mL; R&D Systems) for 24 hours Six wells were used for each culture condition. Total RNA extracted was subjected to real-time RT-PCR analysis for VEGF mRNA (Table 1 ). Data were analyzed by unpaired t-test.
In Vitro Coculture Experiment
A commercial coculture system of human vascular endothelial cells (HUVECs) and fibroblasts (NV kit; Kurabo, Tokyo, Japan) was used to examine effects of cytokines on tube-like structure formation. Using this coculture of HUVECs and fibroblasts, we examined the effect of TNF␣ (5 ng/mL; R&D Systems) on TGF␤1 (0.5 or 1 ng/mL) and VEGF-A (10 ng/mL; Kurabo) stimulation of vessel-like tube formation according to the protocol provided by the manufacturer. Tube tissue was detected by immunostaining with anti-CD31, an endothelium marker. Immune reactivity was visualized by diaminobenzidine color reaction, as previously reported. 
Induction of Stromal Neovascularization by Central Corneal Cauterization in Mice

Tnf␣
-/-mouse in C57BL/6 genetic background was a generous gift from H. Tsutsui (Hyogo Medical University, Hyogo, Japan). 18 Corneal neovascularization from the limbal vessels was induced by central corneal cauterization in one eye of individual WT or Tnf␣ -/-mice using a disposable tool (Optemp; Mod-Tronic Instruments; Brampton, ON, Canada). Experimental mice were killed after 7, 14, or 21 days of injury. Eyes were then enucleated and subjected to cryosection for immunohistochemistry or extraction of total RNA. Ten WT and 10 Tnf␣ -/-corneas were used for histologic examination at each time point. The same numbers of corneas were used for the preparation of total RNA.
Immunohistochemistry
Immunohistochemical examination was performed to detect stromal neovascularization with anti-CD31 and to measure the production of TGF␤1 and VEGF with respective antibodies. Cryosections (7 m) were fixed in cold acetone and processed for immunohistochemical examination, as previously reported. 19, 20 The following antibodies were diluted in PBS: rat monoclonal anti-CD31 (PECAM) antibody, rabbit polyclonal anti-TGF␤1 antibody, and rabbit polyclonal anti-VEGF antibody (all 1:100 in phosphate-buffered saline, Santa Cruz Biotechnology, Santa Cruz, CA). After fluorescein-conjugated secondary antibody reaction and DAPI nuclear counterstaining, the specimens were observed under a fluorescent microscope. Negative control staining was performed by omission of primary antibodies, which did not yield specific staining (data not shown).
Detection of mRNAs of TGF␤1 and VEGF in Burned Corneas
Total RNA extracted from two corneas was subjected to analysis of TGF␤1 and VEGF mRNA by real time RT-PCR. Average values from five specimens (10 corneas) at each time point were analyzed by unpaired t-test using procedures previously reported (Table 1) . 16, 17 
RESULTS
Effects of TGF␤1 and TNF␣ on VEGF Expression by Cultured Fibroblasts
Healing of injured corneas is often complicated by neovascularization with the upregulation of VEGF, a major angiogenic factor in physiological and pathologic conditions. Expression of VEGF might be modulated by various cytokines, such as TGF␤1. In the present study, stromal fibroblast cultures were used to examine whether TNF␣ affects the expression of VEGF. Adding 2 ng/mL recombinant TGF␤1 caused a twofold increase of VEGF mRNA expression by cultured cornea fibroblasts. Upregulation of VEGF mRNA by TGF␤1 was abolished by the addition of TNF␣ (5 and 10 ng/mL) to the medium (Fig. 1) .
Effects of TGF␤1 and TNF␣ on Formation of Vessel-like Structure by HUVECs In Vitro
As shown in Figure 1 , TNF␣ antagonized the effects of TGF␤1 on VEGF expression by cultured fibroblasts. Thus, it is likely
TABLE 1. Sequences of Primers and Probes
Transcript Sequence mTGF␤1 F : 5 Ј-gca aca tgt gga act cta cca gaa-3Ј R: 5Ј-gac gtc aaa aga cag cca ctc-3Ј P: 5Ј-acc ttg gta acc ggc tgc tga ccc-3Ј mVEGF F: 5Ј-agc gga gaa agc att tgt ttg-3Ј R: 5Ј-caa cgc gag tct gtg ttt ttg-3Ј P: 5Ј-cca aga tcc gca gac gtg taa atg ttc c-3 F, forward primer; R, reverse primer; P, probe. (Fig. 2) . Similarly, adding TNF␣ abolished the formation of a vessel-like structure in the presence of VEGF-A alone and VEGF-A combined with TGF␤1 (Fig. 3) .
In Vivo Stromal Neovascularization in Cauterized Corneas
To elucidate the possible roles of TNF␣ on neovascularization after corneal injury, WT and Tnf␣ -/-mice were subjected to corneal cauterization, as described in Materials and Methods. In WT mouse corneas, CD31-labeled neovascularization was not detected at day 7 of cauterization ( Fig. 4A) . At day 14 ( Fig. 4B ) and day 21 (Fig. 4C ) of cauterization, a few new vessels were seen in peripheral corneal stroma adjacent to the limbus. On the other hand, in Tnf␣ -/-mice, stromal neovascularization was readily detectable as early as day 7 (Fig. 4D) and then increased at day 14 ( Fig. 4E ). Dense CD31 immunoreactivity was detected in the central corneal stroma of a Tnf␣ -/-mouse (Fig. 4F) .
Expression of Cytokines during Stromal Neovascularization
Given the results of this study, it is plausible to hypothesize that TNF␣ may have a pivotal role in modulating the expression of angiogenic factors, such as TGF␤1 or VEGF during corneal wound healing. Real-time RT-PCR was used to examine this possibility. Results of real-time RT-PCR showed that cauterization in the central cornea caused an increase of TGF␤1 mRNA expression that persisted until day 21 of cauterization in WT and Tnf␣ -/-mice. TGF␤1 mRNA expression was comparable between WT and Tnf␣ -/-corneas at day 7 of injury, and it was more greatly enhanced in Tnf␣ -/-corneas than in WT corneas at day 21 (Fig. 5A) . Results of immunohistochemical analysis of TGF␤1 protein were consistent with those of realtime RT-PCR in that TGF␤1 protein was faintly detectable, with a minor peak at day 14 in WT corneal stroma throughout the intervals examined. In Tnf␣ -/-mice, this cytokine was readily observed in stroma at all the time points examined (Fig. 5B) .
Expression patterns of VEGF mRNA and protein were similar to those of TGF␤1. Cauterization in central corneas of WT mice induced an increase of VEGF mRNA expression that peaked at day 14 ( Fig. 5C ) and then declined to a lower level at day 21. In contrast, the elevated VEGF mRNA expression maintained at a higher level at days 14 and 21 in Tnf␣ -/-corneas was comparable to that of WT mice. VEGF protein was not seen at day 7 and was faintly detected in WT corneal stroma at days 14 and 21. In Tnf␣ -/-mice, this cytokine was markedly observed in all the time points (Fig. 5D) . VEGF mRNA expression augmented by the lack of TNF␣ was more prominent than by the lack of TGF␤1.
DISCUSSION
It has been demonstrated that inhibiting TNF␣ signaling by blocking TNF␣ receptor did not prevent the development of corneal neovascularization in a rat model. 19 However, the report did not address whether the suppression (or lack) of TNF␣ signal did not affect, or could promote, corneal neovascularization. We previously reported that Tnf␣ -/-mice experienced more severe fibrosis, inflammation, and neovascular- ization in alkali-burned corneas than did WT mice. 16 However, in our previous experimental model of a cornea alkali burn, large areas of ocular surfaces including conjuctiva, limbus, and cornea were injured, and the regenerated ocular surface epithelium was of conjunctival origin associated with neovascularization in the healing cornea. Moreover, in such an alkali burn model, we did not examine whether TNF␣ could antagonize VEGF-based neovascularization that could be greatly enhanced by TGF␤1. Therefore, we did not know the role of TNF␣ in corneal neovascularization or its potential in antagonizing TGF␤1 effects in pathogenesis. 20, 21 In the present study, using in vitro coculture of HUVECs and fibroblasts and in vivo Tnf␣ -/-mice, we have demonstrated that TNF␣ plays a pivotal role in modulating neovascularization. Adding TNF␣ to the culture medium blocked the tube-like structure formation of HUVECs, even in the presence of TGF␤1 and VEGF. Our data demonstrated that TNF␣ can directly counteract VEGF action on tube-like structure formation and can suppress VEGF upregulation stimulated by TGF␤1. In vivo, central corneal cauterization caused an upregulation of TGF␤1 and VEGF (Fig. 5) . Thus, the expression of TNF␣ might reduce neovascularization by antagonizing the effects of TGF␤1 and VEGF. This suggestion is supported by the observation that Tnf␣ -/-mice exhibited more severe neovascularization than did WT mice after central corneal cauterization.
FIGURE 4.
Immunohistochemical detection of CD31 for stromal neovascularization. CD31 immunoreactivity indicates the presence of neovascularization in the affected stroma. At day 7, no CD31 immunoreactivity was observed in a WT cornea (A), and then a few CD31-labeled spots were seen in the peripheral cornea close to the limbus at days 14 (B) and 21 (C). In Tnf␣ -/-mice, at day 7, CD31-labeled neovascularization was readily detected in corneal stroma (D). The density of such neovascularization was increased at days 14 (E) and 21 (F) in Tnf␣ -/-mice. White arrows: CD31-labeled neovascularization; yellow arrows: border between cornea and limbus. e, corneal epithelium; s, stroma; DAPI nuclear localization. Bar, 100 m. Loss of TNF␣ caused persistent upregulation of VEGF (Fig.  5) , which might have accounted for the consequences of augmented neovascularization by central corneal cauterization in Tnf␣ -/-mice. Moreover, in vitro coculture experiments using fibroblast feeder and HUVECs showed that TNF␣ directly blocked the vessel-like tube formation of HUVECs in the presence of TGF␤1 and VEGF. In corneal fibroblast culture, TNF␣ blocked the upregulation of TGF␤1 VEGF, also contributing to the antiangiogenic effects of TNF␣. Thus, the antiangiogenic effect of endogenous TNF␣ can be explained in part by a direct counteraction of TNF␣ against angiogenic reaction promoted by TGF␤1 and VEGF in addition to the suppression of upregulation of such angiogenic growth factors in vivo (Fig. 6) .
Many investigators have reported pleiotropic effects of TNF␣ on various forms of pathogenesis. For example, systemic inflammatory diseases, such as rheumatoid arthritis, can be benefited by the administration of neutralizing anti-TNF␣ antibody, suggesting that reduction in the local TNF␣ level is favorable for suppressing inflammation. 22 Such anti-TNF␣ antibody neutralization is effective in treating bleomycin-induced pulmonary fibrosis.
14 On the other hand, experimental arthritis or pulmonary fibrosis in mice is reportedly more severe in Tnf␣ -/-mice than in WT mice. 13, 15 These findings indicate that partial reduction of TNF␣ and total loss of cytokine exhibit different actions to cells that are implicated in the disease process. It had been suggested that infliximab, a neutralizing antibody against TNF␣ used clinically for the treatment of rheumatoid arthritis, might also be effective in the treatment of inflammatory ocular diseases. 22 However, our present data implicate that the use of infliximab in treating ocular inflammation involving neovascularization may produce adverse effects.
Taken together, our present findings and reports by other investigators indicate that TNF␣ is a two-edged sword in modulating the pathogenesis of various diseases characterized by inflammation and fibrosis. The presence of TNF␣ signaling can alleviate or worsen the diseases. TNF␣ activates a complicated signaling network that includes c-Jun N-terminal kinase (JNK) and nuclear factor-B (NF-B) ; for a review, see Wajant et al. 8 JNK and NF-B signals further activate various pathways, such as activator protein-1 or Smads, by inducing Smad7. 8 However, it has been well shown that signaling through TNF␣ receptor pathways counteract the TGF␤ signal at multiple steps, providing a plausible explanation of our observations. Further studies are needed to delineate the details of signaling cross-talk among soluble factors involving TNF␣.
